63 related articles for article (PubMed ID: 25238773)
1. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Rohan TE; Manson JE; Li J; Ho GY; Xue X; Anderson GL; Kaplan RC; Harris TG; Howard BV; Wylie-Rosett J; Burk RD; Strickler HD
J Natl Cancer Inst; 2009 Jan; 101(1):48-60. PubMed ID: 19116382
[TBL] [Abstract][Full Text] [Related]
2. The association of plasma IGF-I with dietary, lifestyle, anthropometric, and early life factors in postmenopausal women.
Bradbury KE; Balkwill A; Tipper SJ; Crowe FL; Reeves GK; Green J; Beral V; Key TJ;
Growth Horm IGF Res; 2015 Apr; 25(2):90-5. PubMed ID: 25641638
[TBL] [Abstract][Full Text] [Related]
3. Relationship between glaucoma and admixture in postmenopausal African American women.
Garcia L; Qi L; Singh K; Kosoy R; Nassir R; Fijalkowski N; Haan M; Robbins J; Seldin MF
Ethn Dis; 2014; 24(4):399-405. PubMed ID: 25417420
[TBL] [Abstract][Full Text] [Related]
4. A summary of the influence of exogenous estrogen administration across the lifespan on the GH/IGF-1 axis and implications for bone health.
Southmayd EA; De Souza MJ
Growth Horm IGF Res; 2017 Feb; 32():2-13. PubMed ID: 27693042
[TBL] [Abstract][Full Text] [Related]
5. Exogenous estrogen as mediator of racial differences in bioactive insulin-like growth factor-I levels among postmenopausal women.
Jung SY; Vitolins MZ; Paskett ED; Chang S
J Gerontol A Biol Sci Med Sci; 2015 Apr; 70(4):495-502. PubMed ID: 25238773
[TBL] [Abstract][Full Text] [Related]
6. Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women.
Jung SY; Barrington WE; Lane DS; Chen C; Chlebowski R; Corbie-Smith G; Hou L; Zhang ZF; Paek MS; Crandall CJ
Menopause; 2017 Mar; 24(3):288-298. PubMed ID: 27749737
[TBL] [Abstract][Full Text] [Related]
7. Bioavailable insulin-like growth factor-I inversely related to weight gain in postmenopausal women regardless of exogenous estrogen.
Jung SY; Hursting SD; Guindani M; Vitolins MZ; Paskett E; Chang S
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):534-44. PubMed ID: 24363252
[TBL] [Abstract][Full Text] [Related]
8. Associations between time spent sitting and cancer-related biomarkers in postmenopausal women: an exploration of effect modifiers.
Paxton RJ; Jung SY; Vitolins MZ; Fenton J; Paskett E; Pollak M; Hays-Grudo J; Hursting SD; Chang S
Cancer Causes Control; 2014 Nov; 25(11):1427-37. PubMed ID: 25238978
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.
Chlebowski RT; Anderson GL; Aragaki AK; Prentice R
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26546117
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.
Fowke JH; Matthews CE; Yu H; Cai Q; Cohen S; Buchowski MS; Zheng W; Blot WJ
Endocr Relat Cancer; 2010 Mar; 17(1):51-60. PubMed ID: 19786462
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
